Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1223-1227

  Köster, Frank ^a   Schröer, Andreas ^a   Fischer, Dorothea ^a   Horn, Anja Kathrin ^b   Diedrich, Klaus ^a   Friedrich, Michael ^a  

^a Campus Luebeck ^*  (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Breast cancer; DNA mismatch repair; Immunohistochemistry; p53

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROGESTERONE RECEPTOR; PROTEIN MSH2; PROTEIN P53; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TP53 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MISMATCH REPAIR; PROGNOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548556085     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1223     Document Type: Article

References (26)

1. Adem C, Soderberg CL, Cunningham JM, Reynolds C, Sebo TJ, Thibodeau SN, Hartmann LC and Jenkins RB: Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer 107: 580-582, 2003. (Pubitemid 37296118)
2. Catto JW, Xinarianos G, Burton JL, Meuth M and Hamdy FC: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 105: 484-490, 2003. (Pubitemid 36578551)
3. Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN and Halling AC: Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology. Int J Cancer 86: 60-66, 2000. (Pubitemid 30133987)
4. Spagnoletti I, Pizzi C, Galietta A, Di Maio M, Mastranzo P, Daniele S, Limite G, Pettinato G and Contegiacomo A: Loss of hMSH2 expression in primary breast cancer with p53 alterations. Oncol Rep 11: 845-851, 2004.
5. Friedrich M: Analysis of the DNA 'mismatch-repair' enzyme human mut-S-homologon-2 in endometrial cancer on protein- and RNA-level. Eur J Gynaecol Oncol 21: 273-277, 2000.
6. Salvesen HB, MacDonald N, Ryan A, Iversen OE, Jacobs IJ, Akslen LA and Das S: Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 6: 3607-3613, 2000.
7. Friedrich M, Villena-Heinsen C, Meyberg R, Woll-Hermann A, Reitnauer K, Schmidt W, Tilgen W and Reichrath J: Immunohistochemical analysis of DNA 'mismatch-repair' enzyme human Mut-S-Homologon-2 in ovarian carcinomas. Histochem J 31: 717-722, 1999. (Pubitemid 30016130)
8. Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA and Buller RE: Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 98: 2199-2206, 2003. (Pubitemid 37392424)
9. Friedrich M, Villena-Heinsen C, Reitnauer K, Schmidt W, Tilgen W and Reichrath J: Malignancies of the uterine corpus and immunoreactivity score of the DNA 'mismatch-repair' enzyme human Mut-S-homologon-2. J Histochem Cytochem 47: 113-118, 1999. (Pubitemid 29044294)
10. Balogh GA, Russo IH and Russo J: Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. Int J Oncol 23: 411-419, 2003.
11. Bock N, Meden H, Regenbrecht M, Junemann B, Wangerin J and Marx D: Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast. Anticancer Res 20: 119-124, 2000. (Pubitemid 30189742)
12. Friedrich M, Meyberg R, Villena-Heinsen C, Woll-Hermann A, Reitnauer K, Schmidt W, Tilgen and W Reichrath J: Immunohistochemical analysis of DNA mismatch-repair enzyme hMSH-2 and Ki-67 in breast carcinomas. Anticancer Res 19: 3349-3353, 1999. (Pubitemid 30042630)
13. Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C and Schartl M: p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem 275: 37469-37473, 2000. (Pubitemid 32004853)
14. Warnick CT, Dabbas B, Ford CD and Strait KA: Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells. J Biol Chem 276: 27363-27370, 2001.
15. Clodfelter JE, M BG and Drotschmann K: MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability. Nucleic Acids Res 33: 3323-3330, 2005. (Pubitemid 41194476)
16. Drotschmann K, Topping RP, Clodfelter JE and Salsbury FR: Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair 3: 729-742, 2004. (Pubitemid 38716102)
17. Rass K, Gutwein P, Welter C, Meineke V, Tilgen W and Reichrath J: DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines. Histochem J 33: 459-467, 2001. (Pubitemid 34229663)
18. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
19. Ciavattini A, Piccioni M, Tranquilli AL, Filosa A, Pieramici T and Goteri G: Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions. Pathol Res Pract 201: 21-25, 2005. (Pubitemid 40309869)
20. Giarnieri E, Mancini R, Pisani T, Alderisio M and Vecchione A: Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 6: 3600-3606, 2000.
21. Murata H, Khattar NH, Kang Y, Gu L and Li GM: Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene 21: 5696-5703, 2002. (Pubitemid 35333002)
22. Hardisson D, Moreno-Bueno G, Sanchez L, Sarrio D, Suarez A, Calero F and Palacios J: Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability. Mod Pathol 16: 1148-1158, 2003. (Pubitemid 37414210)
23. Murata H, Khattar NH, Gu L and Li GM: Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett 223: 143-150, 2005. (Pubitemid 40693719)
24. Son BH, Ahn SH, Ko CD, Ka IW, Gong GY and Kim JC: Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast. Breast J 10: 20-26, 2004. (Pubitemid 38146375)
25. Cheah PL and Looi LM: P53 immunohistochemical expression: messages in cervical carcinogenesis. Pathology 34: 326-331, 2002.
26. Scherer SJ, Seib T, Seitz G, Dooley S and Welter C: Isolation and characterization of the human mismatch repair gene hMSH2 promoter region. Hum Genet 97: 114-116, 1996. (Pubitemid 26002985)